SCHEMBL1869997

SCHEMBL1869997

CCN(c1ccc2ccccc2c1)c1nc(N)nc(-c2ccc(CC(N)C(=O)O)c(F)c2)n1

nearest known ligand 0.61

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TPH1 P17752 20/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1873078 0.87 TPH1 (0.67) TPH1
SCHEMBL1872985 0.86 TPH1 (0.56) TPH1
SCHEMBL1131296 0.83 TPH1 (0.61) TPH1
SCHEMBL27809408 0.83 TPH1 (0.61) TPH1
SCHEMBL1869970 0.78 TPH1 (0.51) TPH1
SCHEMBL3414026 0.76 TPH1 (1.00) TPH1
SCHEMBL308207 0.76 TPH1 (1.00) TPH1
SCHEMBL3412957 0.75 TPH1 (0.61) TPH1
SCHEMBL1877770 0.74 TPH1 (0.49) TPH1
SCHEMBL1870002 0.74 TPH1 (0.68) TPH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2496231-A1 TRYPTOPHAN HYDROXYLASE INHIBITORS FOR THE TREATMENT OF CANCER Lexicon Pharmaceuticals, Inc. (US) 2012-09-12 EP disclosed
WO-2011056916-A1 TRYPTOPHAN HYDROXYLASE INHIBITORS FOR THE TREATMENT OF CANCER LEXICON PHARMACEUTICALS, INC. (US) 2011-05-12 WO disclosed